We also found that wortmannin and LY294002 significantly increased the percentage of sub-G1 esophageal cancer cell population, whereas addition of Z-DEVD-FMK, a caspase-3 inhibitor, markedly abrogated these effects (Figure 2C). Here, CASP3 is linked to esophageal cancer.